COMMUNIQUÉS West-GlobeNewswire

Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars
17/11/2025
Daix (France), New York City (New York, États-Unis), le 17 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
17/11/2025
Daix (France), New York City (New York, United States), November 17, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]
Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel
17/11/2025
Perspectives from Nxera’s major shareholders provide deeper insights into their investment views and confidence in the Company’s strategy Tokyo, Japan and Cambridge and London, UK, 17 November 2025 – Nxera Pharma Co., [...]
Clue Expands Wearable Integrations with Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Noise and Luna, Unlocking Deeper Insights into Women’s Health
17/11/2025
LONDON, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clue , the #1 women-led period and cycle tracker trusted by over 100 million worldwide, has today announced expanded integrations with leading wearable partners Withings , [...]
RAMSAY SANTE : modalités de mise à disposition ou de consultation des documents préparatoires à l'Assemblée générale de Ramsay Générale de Santé du 11 décembre 2025
17/11/2025
COMMUNIQUÉ DE PRESSE Paris, le 14 novembre 2025 ASSEMBLEE GENERALE MIXTE DU 11 DECEMBRE 2025 Modalités de mise à disposition ou de consultation des documents préparatoires à l’Assemblée générale de Ramsay Générale de [...]
Ramsay Sante : conditions of availability and consultation of the preparatory documents for the Ramsay Générale de Santé General Meeting of December 11, 2025
17/11/2025
PRESS RELEASE Paris, 14 th November 2025 COMBINED GENERAL MEETING OF DECEMBER 11, 2025 Conditions of availability and consultation of the preparatory documents for the Ramsay Générale de Santé General Meeting of [...]
Zelluna ASA: New share capital registered
17/11/2025
Oslo, Norway, 17 November, 2025: Reference is made to the stock exchange announcement made by Zelluna ASA (the "Company") on 3 November 2025 regarding the successful private placement of 5,500,000 new shares (the " [...]
No Crap In It Launches Limited Holiday Christmas Collection and New Primal Super Blend Supplement, Expanding Its All-Natural Wellness Line
17/11/2025
Willis, TX, Nov. 16, 2025 (GLOBE NEWSWIRE) -- No Crap In It, an all-natural wellness and beauty brand proudly made in Texas has announced the launch of its Limited Holiday Collection – a festive new line of clean label [...]
NooCube | Nootropics Brain Booster 2025: Lunch Noocube Brain Productivity Pills for Memory, Focus, Read Ingredients & Side Effects.
16/11/2025
NooCube Effective Nootropics Brain Health Supplement Read NooCube ingredients, Side Effects, Benefits | Does the NooCube really work? New York City, Nov. 16, 2025 (GLOBE NEWSWIRE) -- November 14, 2025, Noocube Brain [...]
Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy
16/11/2025
Shareholders approved all proposals, confirming Faraday Future Intelligent Electric Inc. (“Faraday Future”) as the Company’s new majority and controlling shareholder. Faraday Future will nominate a majority of board [...]
Vnzymes Opens New European Office in Frankfurt to Accelerate Innovation in Animal Nutrition and Sustainable Agriculture
15/11/2025
FRANKFURT, Germany, Nov. 15, 2025 (GLOBE NEWSWIRE) -- Vnzymes, the new brand and European subsidiary of VTR Biotech Group, today officially announced the grand opening of its office in Frankfurt, marking a significant [...]
Sapphire RX Expands Access to Virtual Wellness Care
15/11/2025
KNOXVILLE, Tenn., Nov. 15, 2025 (GLOBE NEWSWIRE) -- Sapphire RX advances digital health accessibility with an innovative telehealth model that prioritizes patient privacy, medical oversight, and personalized care for [...]
Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update
14/11/2025
– Fast Track Designation was granted for BB-301 following U.S. Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for [...]
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
14/11/2025
Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrolimus Data supports [...]
Caring Brands Announces Closing of $4,000,000 Million Uplisting to Nasdaq
14/11/2025
FORT PIERCE, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Caring Brands, Inc. (“Caring Brands” or the “Company”), a wellness consumer products company offering several over-the-counter (OTC) and cosmetic consumer products, [...]
Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy
14/11/2025
Company to host investor conference call and webcast on Monday, November 17th, at 9:00am EST PITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , an AI-driven drug discovery company that [...]
COSCIENS Biopharma Inc. Announces Leadership Change
14/11/2025
TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and pharmaceutical solutions, [...]
Range Impact Reports 3Q 2025 Financial Results
14/11/2025
Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in [...]
Avicanna Reports Q3 2025
14/11/2025
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company” ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization [...]

Pages